Neurogene (NGNE) Non-Current Assets (2013 - 2026)
Neurogene's Non-Current Assets came in at $15.45 million for Q2 2026, down 15.7% from $18.33 million a year earlier and down 5.8% from the prior quarter.
Neurogene (NGNE) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Neurogene's Non-Current Assets was $16.83 million, down 15.0% from FY2024.
- Non-Current Assets has declined in each of the last three years, though with a five-year compound annual growth rate of 1.0% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $19.81 million in FY2024 (-10.9%), $22.23 million in FY2023 (-9.5%), $24.55 million in FY2022 (+27.4%) and $19.27 million in FY2021 (+20.5%).
- The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q3 2023.
- Year-over-year, Non-Current Assets has declined for seven consecutive quarters, with growth averaging 2.3% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in Q3 2024 (growth of 111.2%), and the weakest in Q3 2023 (a decline of 45.3%).
- Business Quant data shows NGNE's Non-Current Assets at $16.39 million (Q1 2026), $16.83 million (Q4 2025) and $17.31 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Neurogene | 642.28 Mn | 642.28 Mn | - | 15.45 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.45 Mn |
| Mar 31, 2026 | 16.39 Mn |
| Dec 31, 2025 | 16.83 Mn |
| Sep 30, 2025 | 17.31 Mn |
| Jun 30, 2025 | 18.33 Mn |
| Mar 31, 2025 | 18.90 Mn |
| Dec 31, 2024 | 19.81 Mn |
| Sep 30, 2024 | 20.47 Mn |
| Jun 30, 2024 | 20.67 Mn |
| Mar 31, 2024 | 21.21 Mn |
| Dec 31, 2023 | 22.23 Mn |
| Sep 30, 2023 | 9.69 Mn |
| Jun 30, 2023 | 10.23 Mn |
| Mar 31, 2023 | 12.82 Mn |
| Dec 31, 2022 | 24.55 Mn |
| Sep 30, 2022 | 17.72 Mn |
| Jun 30, 2022 | 18.54 Mn |
| Mar 31, 2022 | 18.76 Mn |
| Dec 31, 2021 | 19.27 Mn |
| Sep 30, 2021 | 19.44 Mn |
Neurogene Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NGNE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();